The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Epstein-Barr Virus Latent Membrane Protein 2A Preferentially Signals through the Src Family Kinase LynJournal of Virology, 2008
- Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stabilityVirology, 2007
- Epstein-Barr Virus LMP2A Alters In Vivo and In Vitro Models of B-Cell Anergy, but Not Deletion, in Response to AutoantigenJournal of Virology, 2005
- Epstein–Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivationJournal of General Virology, 2005
- Epstein–Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathwayOncogene, 2004
- Cbl-mediated Degradation of Lyn and Fyn Induced by Constitutive Fibroblast Growth Factor Receptor-2 Activation Supports Osteoblast DifferentiationJournal of Biological Chemistry, 2004
- WW Domain HECT E3s Target Cbl RING Finger E3s for Proteasomal DegradationJournal of Biological Chemistry, 2003
- Hematopoietic cell‐specific adapter proteins, SLP‐76 and BLNK, effectively activate NF‐AT as well as NF‐κB by Syk and Tec PTKs in non‐lymphoid cell linesFEBS Letters, 2001
- Epstein--Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein--Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma linesJournal of General Virology, 1996
- Reconstitution of the B Cell Antigen Receptor Signaling Components in COS CellsJournal of Biological Chemistry, 1995